Barclays’s Nomura Holdings NMR Stock Holding History

Barclays’s Portfolio NMR Stock Details NMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-2,500	Closed	-$19K	–	7544
2013 Q2	$19K	Buy	+2,500	New	+$19.5K	﹤0.01%	6862

Other funds holding NMR

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

OSAM

O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barclays's NMR Position: Q4 2021 in Review

Barclays sold out of Nomura Holdings (NMR) in Q4 2021, closing a stake of 1,326 shares — an estimated $7K sold.

Barclays first reported a position in NMR in Q2 2013 and held it in 22 quarters. The position peaked at $507K in Q2 2014. 126 funds tracked by Wall St. Rank hold NMR as of Q4 2021.

Barclays reported no remaining Nomura Holdings position as of Q4 2021 after selling out during the quarter.
Barclays sold 1,326 Nomura Holdings shares in Q4 2021, an estimated $7K.
Barclays first reported a position in Nomura Holdings in Q2 2013 and held it in 22 quarters.
Barclays's Nomura Holdings position peaked at $507K in Q2 2014.
126 funds tracked by Wall St. Rank held Nomura Holdings as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.